# US 2016/0257641 A1 · Novel alkylene derivatives

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0257641 A1
- Document ID: US20160257641A1
- Status: Published application
- Kind: A1
- Application number: 15/029,031
- Filed: 2014-10-17
- Published: 2016-09-08
- Earliest claimed: 2013-10-17
- Assignees: Shionogi & Co., Ltd.
- Applicants: Shionogi & Co., Ltd.
- Inventors: Naotake KOBAYASHI; Kentarou ASAHI; Yutaka TOMIDA; Masahide OHDAN; Masataka FUMOTO; Yoshikazu SASAKI; Kana KURAHASHI; Takatsugu INOUE; Tomomi URABE; Yuji NISHIURA; Masafumi IWATSU; Keisuke MIYAZAKI; Naoki OHYABU; Toshihiro WADA; Manabu KATOU
- Web page: https://patentgrep.com/patent/US20160257641A1

## CPC

- C07C 233/22: having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
- A61P 3/04: Anorexiants; Antiobesity agents
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07C 233/18: having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
- C07C 233/31: with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C 275/10: being further substituted by singly-bound oxygen atoms
- C07D 213/64: attached in position 2 or 6
- C07D 213/69: Two or more oxygen atoms
- C07D 231/56: Benzopyrazoles; Hydrogenated benzopyrazoles
- C07D 239/80: Oxygen atoms
- C07D 241/18: Oxygen or sulfur atoms
- C07D 261/20: condensed with carbocyclic rings or ring systems
- C07D 263/56: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D 267/14: condensed with one six-membered ring
- C07D 277/20: having two or three double bonds between ring members or between ring members and non-ring members
- C07D 277/34: Oxygen atoms
- C07D 277/64: with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
- C07D 277/68: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D 401/12: linked by a chain containing hetero atoms as chain links
- C07D 401/14: containing three or more hetero rings
- C07D 403/12: linked by a chain containing hetero atoms as chain links
- C07D 403/14: containing three or more hetero rings
- C07D 413/12: linked by a chain containing hetero atoms as chain links
- C07D 417/12: linked by a chain containing hetero atoms as chain links
- C07C 2601/02: with a three-membered ring
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

The object of the present invention is to provide novel compounds having ACC2 inhibiting activity. In addition, the object of the present invention is to provide a pharmaceutical composition comprising the compound. A compound of formula (I): wherein R1 is substituted or unsubstituted fused aromatic heterocyclyl etc., ring A is substituted or unsubstituted non-aromatic carbocycle etc., -L1- is —O—(CR6R7)m- etc., -L2- is —O—(CR6R7)n- etc., each R6 and R7 are independently hydrogen, halogen etc., R2 is substituted or unsubstituted alkyl, R3 is hydrogen or substituted or unsubstituted alkyl, R4 is substituted or unsubstituted alkylcarbonyl etc.

## Claims

### Claim 1

A compound of Formula (I):
or its pharmaceutically acceptable salt,
wherein
R1 is substituted or unsubstituted fused aromatic heterocyclyl, substituted or unsubstituted fused aromatic carbocyclyl, substituted or unsubstituted non-aromatic heterocyclyl, substituted or unsubstituted non-aromatic carbocyclyl, the group represented by Formula:
or substituted or unsubstituted 5-membered aromatic heterocyclyl,
X1 is N or C(Rx1),
X2 is N or C(Rx2),
X3 is N or C(Rx3),
X4 is N or COO,
each Rx1, Rx2, Rx3, and Rx4 is independently hydrogen, halogen, hydroxy, carboxy, cyano, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted alkyloxy, substituted or unsubstituted alkenyloxy, substituted or unsubstituted alkynyloxy, substituted or unsubstituted alkylsulfanyl, substituted or unsubstituted alkenylsulfanyl, substituted or unsubstituted alkynylsulfanyl, substituted or unsubstituted amino, substituted or unsubstituted carbamoyl, substituted or unsubstituted sulfamoyl, substituted or unsubstituted alkylcarbonyl, substituted or unsubstituted alkenylcarbonyl, substituted or unsubstituted alkynylcarbonyl, substituted or unsubstituted alkyloxycarbonyl, substituted or unsubstituted alkenyloxycarbonyl, substituted or unsubstituted alkynyloxycarbonyl, substituted or unsubstituted alkylsulfonyl, substituted or unsubstituted alkenylsulfonyl, substituted or unsubstituted alkynylsulfonyl, substituted or unsubstituted non-aromatic carbocyclylsulfonyl, substituted or unsubstituted aromatic carbocyclylsulfonyl, substituted or unsubstituted non-aromatic heterocyclylsulfonyl, substituted or unsubstituted aromatic heterocyclylsulfonyl or substituted or unsubstituted sulfamoyl,
Rx5 is halogen, hydroxy, carboxy, cyano, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted alkyloxy, substituted or unsubstituted alkenyloxy, substituted or unsubstituted alkynyloxy, substituted or unsubstituted alkylsulfanyl, substituted or unsubstituted alkenylsulfanyl, substituted or unsubstituted alkynylsulfanyl, substituted or unsubstituted amino, substituted or unsubstituted carbamoyl, substituted or unsubstituted alkylcarbonyl, substituted or unsubstituted alkenylcarbonyl, substituted or unsubstituted alkynylcarbonyl, substituted or unsubstituted alkyloxycarbonyl, substituted or unsubstituted alkenyloxycarbonyl, substituted or unsubstituted alkynyloxycarbonyl, substituted or unsubstituted alkylsulfonyl, substituted or unsubstituted alkenylsulfonyl, substituted or unsubstituted alkynylsulfonyl, substituted or unsubstituted non-aromatic carbocyclylsulfonyl, substituted or unsubstituted aromatic carbocyclylsulfonyl, substituted or unsubstituted non-aromatic heterocyclylsulfonyl, substituted or unsubstituted aromatic heterocyclylsulfonyl or substituted or unsubstituted sulfamoyl,
ring A is substituted or unsubstituted non-aromatic carbocycle, substituted or unsubstituted non-aromatic heterocycle, substituted or unsubstituted aromatic carbocycle or substituted or unsubstituted aromatic heterocycle,
-L1- is —O—(CR6R7)m- or —N(R8)—(CR6R7)m-,
-L2- is —O—(CR6R7)n-, —O—CR6═CR7—, —(CR6R7)n- or —C(═O)—(CR6R7)n-,
each R6 is independently hydrogen, halogen, cyano, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl or substituted or unsubstituted alkynyl,
each R7 is independently hydrogen, halogen, cyano, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl or substituted or unsubstituted alkynyl, or R6 and R7 on the same carbon atom may be taken together with the carbon atom to form ring, or R2 is taken together with either R6 or R7 to form ring,
each m is independently an integer of 0, 1, 2 or 3,
each n is independently an integer of 1, 2 or 3,
R2 is substituted or unsubstituted alkyl,
R3 is hydrogen or substituted or unsubstituted alkyl,
R4 is substituted or unsubstituted alkylcarbonyl, substituted or unsubstituted alkenylcarbonyl, substituted or unsubstituted alkynylcarbonyl, substituted or unsubstituted non-aromatic carbocyclylcarbonyl, substituted or unsubstituted aromatic carbocyclylcarbonyl, substituted or unsubstituted non-aromatic heterocyclylcarbonyl, substituted or unsubstituted aromatic heterocyclylcarbonyl, substituted or unsubstituted alkyloxycarbonyl, substituted or unsubstituted alkenyloxycarbonyl, substituted or unsubstituted alkynyloxycarbonyl, substituted or unsubstituted non-aromatic carbocyclyloxycarbonyl, substituted or unsubstituted aromatic carbocyclyloxycarbonyl, substituted or unsubstituted non-aromatic heterocyclyloxycarbonyl, substituted or unsubstituted aromatic heterocyclyloxycarbonyl, substituted or unsubstituted carbamoyl, substituted or unsubstituted alkylsulfonyl, substituted or unsubstituted alkenylsulfonyl, substituted or unsubstituted alkynylsulfonyl, substituted or unsubstituted non-aromatic carbocyclylsulfonyl, substituted or unsubstituted aromatic carbocyclylsulfonyl, substituted or unsubstituted non-aromatic heterocyclylsulfonyl, substituted or unsubstituted aromatic heterocyclylsulfonyl or substituted or unsubstituted sulfamoyl;
provided that the following compounds are excluded,
(i) the compounds wherein R1 is a substituent selected from Substituent group α (Substituent group α: unsubstituted phenyl and substituted or unsubstituted aromatic heterocyclyl) and quinolinyl substituted with two alkyloxy groups, ring A is substituted pyrrolidine, and -L2- is —C(═O)—(CR6R7)n-,
(ii) the compounds wherein ring A is nitrogen-containing non-aromatic heterocycle, -L2- is —C(═O)—(CR6R7)n-, and the atom on ring A bonded to -L2- is nitrogen,
(iii) the compounds wherein R1 is benzimidazolyl substituted with substituted or unsubstituted aromatic heterocyclylalkyl or substituted or unsubstituted non-aromatic heterocyclylalkyl, ring A is piperidine, -L1- is —NH—, -L2- is —CH2—, and R4 is tert-butyloxycarbonyl,
(iv) the compounds wherein R1 is substituted or unsubstituted fused aromatic heterocyclyl represented by Formula:
wherein
ring B is 5-membered, and ring C is 6-membered,
and -L2- is —C(═O)—(CR6R7)n-,
(v) the compounds wherein X1 is C(Rx1), X2 is C(Rx2), X3 is C(Rx3), X4 is C(Rx4), Rx5 is unsubstituted carbamoyl, ring A is unsubstituted cyclohexane, -L1- is —N(H)—, -L2- is —C(═O)—, and R4 is alkylcarbonyl substituted with amino or unsubstituted alkyloxycarbonyl,
and
(vi) the following compounds:
(1-a) A compound of Formula (I):
or its pharmaceutical acceptable salt,
wherein
R1 is substituted or unsubstituted fused aromatic heterocyclyl, substituted or unsubstituted fused aromatic carbocyclyl, substituted or unsubstituted non-aromatic heterocyclyl, substituted or unsubstituted non-aromatic carbocyclyl, the group represented by Formula:
or substituted or unsubstituted 5-membered aromatic heterocyclyl,
X1 is N or C(Rx1),
X2 is N or C(Rx2),
X3 is N or C(Rx3),
X4 is N or C(Rx4),
each Rx1, Rx2, Rx3, and Rx4 is independently hydrogen, halogen, hydroxy, carboxy, cyano, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted alkyloxy, substituted or unsubstituted alkenyloxy, substituted or unsubstituted alkynyloxy, substituted or unsubstituted alkylsulfanyl, substituted or unsubstituted alkenylsulfanyl, substituted or unsubstituted alkynylsulfanyl, substituted or unsubstituted amino, substituted or unsubstituted carbamoyl, substituted or unsubstituted sulfamoyl, substituted or unsubstituted alkylcarbonyl, substituted or unsubstituted alkenylcarbonyl, substituted or unsubstituted alkynylcarbonyl, substituted or unsubstituted alkyloxycarbonyl, substituted or unsubstituted alkenyloxycarbonyl, substituted or unsubstituted alkynyloxycarbonyl, substituted or unsubstituted alkylsulfonyl, substituted or unsubstituted alkenylsulfonyl, substituted or unsubstituted alkynylsulfonyl, substituted or unsubstituted non-aromatic carbocyclylsulfonyl, substituted or unsubstituted aromatic carbocyclylsulfonyl, substituted or unsubstituted non-aromatic heterocyclylsulfonyl, substituted or unsubstituted aromatic heterocyclylsulfonyl or substituted or unsubstituted sulfamoyl,
Rx5 is halogen, hydroxy, carboxy, cyano, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted alkyloxy, substituted or unsubstituted alkenyloxy, substituted or unsubstituted alkynyloxy, substituted or unsubstituted alkylsulfanyl, substituted or unsubstituted alkenylsulfanyl, substituted or unsubstituted alkynylsulfanyl, substituted or unsubstituted amino, substituted or unsubstituted carbamoyl, substituted or unsubstituted alkylcarbonyl, substituted or unsubstituted alkenylcarbonyl, substituted or unsubstituted alkynylcarbonyl, substituted or unsubstituted alkyloxycarbonyl, substituted or unsubstituted alkenyloxycarbonyl, substituted or unsubstituted alkynyloxycarbonyl, substituted or unsubstituted alkylsulfonyl, substituted or unsubstituted alkenylsulfonyl, substituted or unsubstituted alkynylsulfonyl, substituted or unsubstituted non-aromatic carbocyclylsulfonyl, substituted or unsubstituted aromatic carbocyclylsulfonyl, substituted or unsubstituted non-aromatic heterocyclylsulfonyl, substituted or unsubstituted aromatic heterocyclylsulfonyl or substituted or unsubstituted sulfamoyl,
ring A is substituted or unsubstituted non-aromatic carbocycle, substituted or unsubstituted non-aromatic heterocycle, substituted or unsubstituted aromatic carbocycle or substituted or unsubstituted aromatic heterocycle,
-L1- is —O—(CR6R7)m- or —N(R8)—(CR6R7)m-,
-L2- is —O—(CR6R7)n-, —O—CR6═CR7—, —(CR6R7)n- or —C(═O)—(CR6R7)n-,
each R6 is independently hydrogen, halogen, cyano, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl or substituted or unsubstituted alkynyl,
each R7 is independently hydrogen, halogen, cyano, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl or substituted or unsubstituted alkynyl, or R6 and R7 on the same carbon atom may be taken together with the carbon atom to form ring, or R2 is taken together with either R6 or R7 to form ring,
each m is independently an integer of 0, 1, 2 or 3,
each n is independently an integer of 1, 2 or 3,
R2 is substituted or unsubstituted alkyl,
R3 is hydrogen or substituted or unsubstituted alkyl,
R4 is substituted or unsubstituted alkylcarbonyl, substituted or unsubstituted alkenylcarbonyl, substituted or unsubstituted alkynylcarbonyl, substituted or unsubstituted non-aromatic carbocyclylcarbonyl, substituted or unsubstituted aromatic carbocyclylcarbonyl, substituted or unsubstituted non-aromatic heterocyclylcarbonyl, substituted or unsubstituted aromatic heterocyclylcarbonyl, substituted or unsubstituted alkyloxycarbonyl, substituted or unsubstituted alkenyloxycarbonyl, substituted or unsubstituted alkynyloxycarbonyl, substituted or unsubstituted non-aromatic carbocyclyloxycarbonyl, substituted or unsubstituted aromatic carbocyclyloxycarbonyl, substituted or unsubstituted non-aromatic heterocyclyloxycarbonyl, substituted or unsubstituted aromatic heterocyclyloxycarbonyl, substituted or unsubstituted carbamoyl, substituted or unsubstituted alkylsulfonyl, substituted or unsubstituted alkenylsulfonyl, substituted or unsubstituted alkynylsulfonyl, substituted or unsubstituted non-aromatic carbocyclylsulfonyl, substituted or unsubstituted aromatic carbocyclylsulfonyl, substituted or unsubstituted non-aromatic heterocyclylsulfonyl, substituted or unsubstituted aromatic heterocyclylsulfonyl or substituted or unsubstituted sulfamoyl;
provided that the following compounds are excluded,
(i) the compounds wherein R1 is a substituent selected from Substituent group α (Substituent group α: unsubstituted phenyl and substituted or unsubstituted aromatic heterocyclyl) and quinolinyl substituted with two alkyloxy groups, ring A is substituted pyrrolidine, and -L2- is —C(═O)—(CR6R7)n-,
(ii) the compounds wherein ring A is nitrogen-containing non-aromatic heterocycle, -L2- is —C(═O)—(CR6R7)n-, and the atom on ring A bonded to -L2- is nitrogen,
(iii) the compounds wherein R1 is benzimidazolyl or imidazopyridyl substituted with substituted or unsubstituted aromatic heterocyclylalkyl or substituted or unsubstituted non-aromatic heterocyclylalkyl, ring A is piperidine, -L′- is —NH—, -L2- is —CH2—, and R4 is tert-butyloxycarbonyl,
(iv) the compounds wherein R1 is substituted or substituted fused aromatic heterocyclyl represented by Formula:
wherein
ring B is 5-membered, and ring C is 6-membered,
(iv) the compounds wherein X′ is C(Rx1), X2 is C(Rx2), X3 is C(Rx3), X4 is C(Rx4), Rx5 is unsubstituted carbamoyl, ring A is unsubstituted cyclohexane, -L1- is —N(H)—, -L2- is —C(═O)—, and R4 is alkylcarbonyl substituted with amino or unsubstituted alkyloxycarbonyl,
and
(v) the following compounds:

### Claim 2 (depends on 1)

The compound or its pharmaceutically acceptable salt according to claim 1, wherein ring A is substituted or unsubstituted cyclobutane, substituted or unsubstituted cyclopentane, substituted or unsubstituted azetidine, substituted or unsubstituted oxetane, substituted or unsubstituted thietane, substituted or unsubstituted pyrrolidine, substituted or unsubstituted tetrahydrofuran, substituted or unsubstituted thiolane, substituted or unsubstituted piperidine, substituted or unsubstituted morpholine, substituted or unsubstituted tetrahydropyran, substituted or unsubstituted tetrahydrothiopyran, substituted or unsubstituted pyrrole, substituted or unsubstituted furan, substituted or unsubstituted thiophene, substituted or unsubstituted imidazole, substituted or unsubstituted pyrazole, substituted or unsubstituted oxazole, substituted or unsubstituted isoxazole, substituted or unsubstituted thiazole, substituted or unsubstituted isothiazole, substituted or unsubstituted oxadiazole, substituted or unsubstituted thiadiazole, substituted or unsubstituted pyridine, substituted or unsubstituted pyrimidine, substituted or unsubstituted pyrazine or substituted or unsubstituted pyridazine.

### Claim 3 (depends on 1)

The compound or its pharmaceutically acceptable salt according to claim 1, wherein ring A is substituted or unsubstituted cyclobutane, substituted or unsubstituted cyclohexaneubstituted or unsubstituted benzene, substituted or unsubstituted piperidine, substituted or unsubstituted pyrazine, substituted or unsubstituted pyrimidine or substituted or unsubstituted thiazole.

### Claim 4 (depends on 1)

The compound or its pharmaceutically acceptable salt according to claim 1, wherein R1 is substituted or unsubstituted benzothiazolyl, substituted or unsubstituted benzoxazolyl, substituted or unsubstituted benzoimidazolyl, substituted or unsubstituted indolyl, substituted or unsubstituted indazolyl, substituted or unsubstituted isoquinolyl, substituted or unsubstituted quinoxalinyl, substituted or unsubstituted naphtalenyl, substituted or unsubstituted aziridinyl, substituted or unsubstituted oxyranyl, substituted or unsubstituted thiiranyl, substituted or unsubstituted azetidinyl, substituted or unsubstituted oxetanyl, substituted or unsubstituted thietanyl, substituted or unsubstituted pirrolidinyl, substituted or unsubstituted tetrahydrofuranyl, substituted or unsubstituted tetrahydrothiophenyl, substituted or unsubstituted piperidinyl, substituted or unsubstituted piperidino, substituted or unsubstituted tetrahydropyranyl, substituted or unsubstituted tetrahydropyranyl, substituted or unsubstituted piperazinyl, substituted or unsubstituted morpholinyl, substituted or unsubstituted morpholino, substituted or unsubstituted thiomorpholinyl, substituted or unsubstituted thiomorpholino, substituted or unsubstituted cyclobutanyl, the group represented by Formula:
or substituted or unsubstituted 5-membered aromatic heterocyclyl.

### Claim 5 (depends on 1)

The compound or its pharmaceutically acceptable salt according to claim 1, wherein R1 is substituted or unsubstituted naphtalenyl, substituted or unsubstituted pyrimidinyl, substituted or unsubstituted dihydroindenyl, substituted or unsubstituted dihydrobenzofuranyl, substituted or unsubstituted indolinyl, substituted or unsubstituted tetrahydroisoquinolyl, substituted or unsubstituted benzoxazolyl, substituted or unsubstituted benzothiazolyl, substituted or unsubstituted benzopyrazolyl, substituted or unsubstituted benzoisothiazolyl or substituted or unsubstituted oxazolinyl.

### Claim 6 (depends on 1)

The compound or its pharmaceutically acceptable salt according to claim 1, wherein R1 is substituted or unsubstituted naphtalenyl, substituted or unsubstituted dihydroindenyl, substituted or unsubstituted dihydrobenzofuranyl, substituted or unsubstituted indolinyl, substituted or unsubstituted tetrahydroisoquinolinyl, substituted or unsubstituted benzoxazolyl, substituted or unsubstituted benzothiazolyl, substituted or unsubstituted benzopyrazolyl, substituted or unsubstituted benzoisothiazolyl, substituted or unsubstituted oxazolinyl, or the group represented by Formula:

### Claim 7 (depends on 1)

The compound or its pharmaceutically acceptable salt according to claim 1, wherein R1 is substituted or unsubstituted benzothiazolyl, substituted or unsubstituted benzoxazolyl, substituted or unsubstituted benzimidazolyl, substituted or unsubstituted benzopyrazolyl, substituted or unsubstituted thiazolopyridinyl, substituted or unsubstituted indolyl, substituted or unsubstituted indazolyl, substituted or unsubstituted isoquinolyl, substituted or unsubstituted quinazolinyl, or substituted or unsubstituted quinoxalinyl.

### Claim 8 (depends on 1)

The compound or its pharmaceutically acceptable salt according to claim 1, wherein R1 is the group represented by Formula:
wherein
each R1a, R1b, R1c, R1d, and R1e is independently hydrogen, halogen, hydroxy, carboxy, cyano, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted alkyloxy, substituted or unsubstituted alkenyloxy, substituted or unsubstituted alkynyloxy, substituted or unsubstituted alkylsulfanyl, substituted or unsubstituted alkenylsulfanyl, substituted or unsubstituted alkynylsulfanyl, substituted or unsubstituted amino, substituted or unsubstituted carbamoyl, substituted or unsubstituted sulfamoyl, substituted or unsubstituted alkylcarbonyl, substituted or unsubstituted alkenylcarbonyl, substituted or unsubstituted alkynylcarbonyl, substituted or unsubstituted alkyloxycarbonyl, substituted or unsubstituted alkenyloxycarbonyl, or substituted or unsubstituted alkynyloxycarbonyl,
R1f is hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted alkylcarbonyl, substituted or unsubstituted alkenylcarbonyl, or substituted or unsubstituted alkynylcarbonyl.

### Claim 9 (depends on 8)

The compound or its pharmaceutically acceptable salt according to claim 8, wherein R1a is substituted or unsubstituted alkyl, or substituted or unsubstituted alkyloxy.

### Claim 10 (depends on 1)

The compound or its pharmaceutically acceptable salt according to claim 1, wherein R4 is substituted or unsubstituted alkylcarbonyl.

### Claim 11 (depends on 10)

The compound or its pharmaceutically acceptable salt according to claim 10, wherein R4 is methylcarbonyl.

### Claim 12 (depends on 1)

The compound or its pharmaceutically acceptable salt according to claim 1, wherein R4 is substituted or unsubstituted non-aromatic carbocyclylcarbonyl, substituted or unsubstituted non-aromatic heterocyclylcarbonyl, or substituted or unsubstituted aromatic carbocyclylcarbonyl, or substituted or unsubstituted carbamoyl.

### Claim 13 (depends on 1)

The compound or its pharmaceutically acceptable salt according to claim 1, wherein m is 0.

### Claim 14 (depends on 1)

The compound or its pharmaceutically acceptable salt according to claim 1, wherein -L2- is —O—(CR6R7)n-.

### Claim 15 (depends on 1)

The compound or its pharmaceutically acceptable salt according to claim 1, wherein n is 1.

### Claim 16 (depends on 1)

The compound or its pharmaceutically acceptable salt according to claim 1, wherein -L2- is —O—(CR6R7)—, R2 is taken together with either R6 or R7 to form ring.

### Claim 17 (depends on 1)

The compound or its pharmaceutically acceptable salt according to claim 1, wherein R1 is the group represented by Formula:
wherein each symbols is as defined above,
ring A is the group represented by Formula:
wherein R8 is halogen, cyano, hydroxy, carboxy, oxo, substituted or unsubstituted alkyl, substituted or unsubstituted alkyloxy or substituted or unsubstituted amino, and p is an integer of 0 to 4,
each R6 is independently hydrogen, halogen, cyano, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl or substituted or unsubstituted alkynyl,
each R7 is independently hydrogen, halogen, cyano, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl or substituted or unsubstituted alkynyl, or
R6 and R7 on the same carbon atom are taken together to form ring.

### Claim 18 (depends on 17)

The compound or its pharmaceutically acceptable salt according to claim 17, wherein -L1- is —O—(CR6R7)m-, and -L2- is —O—(CR6R7)n- or —(CR6R7)n-.

### Claim 19 (depends on 1)

The compound or its pharmaceutically acceptable salt according to claim 1, wherein Formula (I) is Formula:

### Claim 20 (depends on 1)

A pharmaceutical composition, which comprises the compound or its pharmaceutically acceptable salt according to claim 1.

### Claim 21 (depends on 20)

A pharmaceutical composition according to the claim 20 for treatment or prevention of a disease associated with ACC2.

### Claim 22 (depends on 1)

A method for treatment or prevention of a disease associated with ACC2 characterized by administering the compound its pharmaceutically acceptable salt according to claim 1.

### Claim 23 (depends on 1)

The compound or its pharmaceutically acceptable salt of claim 1 for treatment or prevention of a disease associated with ACC2.
